A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

NCT00473330 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

377

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Macular Edema

Interventions

DRUG: Ranibizumab
DRUG: Sham injection

Sponsor

Genentech, Inc.